Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar 21;20(6):1426.
doi: 10.3390/ijms20061426.

Impact of ERK5 on the Hallmarks of Cancer

Affiliations
Review

Impact of ERK5 on the Hallmarks of Cancer

Barbara Stecca et al. Int J Mol Sci. .

Abstract

Extracellular signal-regulated kinase 5 (ERK5) belongs to the mitogen-activated protein kinase (MAPK) family that consists of highly conserved enzymes expressed in all eukaryotic cells and elicits several biological responses, including cell survival, proliferation, migration, and differentiation. In recent years, accumulating lines of evidence point to a relevant role of ERK5 in the onset and progression of several types of cancer. In particular, it has been reported that ERK5 is a key signaling molecule involved in almost all the biological features of cancer cells so that its targeting is emerging as a promising strategy to suppress tumor growth and spreading. Based on that, in this review, we pinpoint the hallmark-specific role of ERK5 in cancer in order to identify biological features that will potentially benefit from ERK5 targeting.

Keywords: BMK1; ERK5; MAPK7; MEK5; apoptosis; cancer; cell proliferation; invasion; metastasis; targeted therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interests.

Figures

Figure 1
Figure 1
Schematic representation of the MEK5–extracellular signal-regulated kinase 5 (ERK5) pathway with activators and downstream effectors.
Figure 2
Figure 2
Connections between ERK5 and the hallmarks of cancer. Established (bold) and proposed (nonbold) downstream mediators of ERK5 are indicated. Abbreviations used in the figure are listed in the “Abbreviations” paragraph.

References

    1. Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell. 2011;144:646–674. doi: 10.1016/j.cell.2011.02.013. - DOI - PubMed
    1. Wang X., Tournier C. Regulation of cellular functions by the ERK5 signalling pathway. Cell. Signal. 2006;18:753–760. doi: 10.1016/j.cellsig.2005.11.003. - DOI - PubMed
    1. Drew B.A., Burow M.E., Beckman B.S. MEK5/ERK5 pathway: The first fifteen years. Biochim. Biophys. Acta. 2012;1825:37–48. doi: 10.1016/j.bbcan.2011.10.002. - DOI - PMC - PubMed
    1. Abe J., Kusuhara M., Ulevitch R.J., Berk B.C., Lee J.D. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J. Biol. Chem. 1996;271:16586–16590. doi: 10.1074/jbc.271.28.16586. - DOI - PubMed
    1. Suzaki Y., Yoshizumi M., Kagami S., Koyama A.H., Taketani Y., Houchi H., Tsuchiya K., Takeda E., Tamaki T. Hydrogen peroxide stimulates c-Src-mediated big mitogen-activated protein kinase 1 (BMK1) and the MEF2C signaling pathway in PC12 cells: Potential role in cell survival following oxidative insults. J. Biol. Chem. 2002;277:9614–9621. doi: 10.1074/jbc.M111790200. - DOI - PubMed

MeSH terms

LinkOut - more resources